Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Nau

Showing results (191-200 of 317) with videos related to

Pageof 32
Sort By:
Life Sciences|January 1, 1995
Antiepileptic drugs alter endogenous retinoid concentrations: a possible mechanism of teratogenesis of anticonvulsant therapyH Nau, G Tzimas, M Mondry, et al.
Archives of Toxicology|January 1, 1996
Stereoselective distribution of the teratogenic thalidomide analogue EM12 in the early embryo of marmoset monkey, Wistar rat and NMRI mouseH J Schmahl, L Dencker, C Plum, et al.
Journal of Chromatography. A|April 5, 1996
Fully automated determination of selective retinoic acid receptor ligands in mouse plasma and tissue by reversed-phase liquid chromatography coupled on-line with solid-phase extractionH M Arafa, F M Hamada, M M Elmazar, et al.
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|February 1, 1997
Correlation of in vitro anti-proliferative potential with in vivo teratogenicity in a series of valproate analoguesC Courage-Maguire, C L Bacon, H Nau, et al.
Toxicology Letters|January 1, 1995
Transplacental pharmacokinetics of a synthetic retinoid which is not bound by mouse embryonic cellular retinoic acid-binding proteinJ O Sass, J Hartmann, I Chahoud, et al.
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|January 1, 1983
[Antiepileptic drugs in the newborn. Clinical and pharmacological data]D Rating, H Nau, W Kuhnz, et al.
Toxicology and Applied Pharmacology|September 23, 1997
RARalpha-mediated teratogenicity in mice is potentiated by an RXR agonist and reduced by an RAR antagonist: dissection of retinoid receptor-induced pathwaysM M Elmazar, R Rühl, U Reichert, et al.
Toxicology and Applied Pharmacology|August 1, 1989
Teratogenicity and placental transfer of all-trans-, 13-cis-, 4-oxo-all-trans-, and 4-oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in miceJ Creech Kraft, B Löfberg, I Chahoud, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|October 1, 1988
Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley ratsP E Binkerd, J M Rowland, H Nau, et al.
Pediatric Pharmacology (New York, N.Y.)|January 1, 1983
Enzyme induction in neonates after fetal exposure to antiepileptic drugsD Rating, E Jäger-Roman, H Nau, et al.
Pageof 32

Showing results (191-200 of 317) with videos related to

Sort By:
Pageof 32
Life Sciences|January 1, 1995
Antiepileptic drugs alter endogenous retinoid concentrations: a possible mechanism of teratogenesis of anticonvulsant therapyH Nau, G Tzimas, M Mondry, et al.
Archives of Toxicology|January 1, 1996
Stereoselective distribution of the teratogenic thalidomide analogue EM12 in the early embryo of marmoset monkey, Wistar rat and NMRI mouseH J Schmahl, L Dencker, C Plum, et al.
Journal of Chromatography. A|April 5, 1996
Fully automated determination of selective retinoic acid receptor ligands in mouse plasma and tissue by reversed-phase liquid chromatography coupled on-line with solid-phase extractionH M Arafa, F M Hamada, M M Elmazar, et al.
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|February 1, 1997
Correlation of in vitro anti-proliferative potential with in vivo teratogenicity in a series of valproate analoguesC Courage-Maguire, C L Bacon, H Nau, et al.
Toxicology Letters|January 1, 1995
Transplacental pharmacokinetics of a synthetic retinoid which is not bound by mouse embryonic cellular retinoic acid-binding proteinJ O Sass, J Hartmann, I Chahoud, et al.
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|January 1, 1983
[Antiepileptic drugs in the newborn. Clinical and pharmacological data]D Rating, H Nau, W Kuhnz, et al.
Toxicology and Applied Pharmacology|September 23, 1997
RARalpha-mediated teratogenicity in mice is potentiated by an RXR agonist and reduced by an RAR antagonist: dissection of retinoid receptor-induced pathwaysM M Elmazar, R Rühl, U Reichert, et al.
Toxicology and Applied Pharmacology|August 1, 1989
Teratogenicity and placental transfer of all-trans-, 13-cis-, 4-oxo-all-trans-, and 4-oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in miceJ Creech Kraft, B Löfberg, I Chahoud, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|October 1, 1988
Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley ratsP E Binkerd, J M Rowland, H Nau, et al.
Pediatric Pharmacology (New York, N.Y.)|January 1, 1983
Enzyme induction in neonates after fetal exposure to antiepileptic drugsD Rating, E Jäger-Roman, H Nau, et al.
Pageof 32